Diversity-based screening continues to be a vital tool for drug discovery. Efficiency and productivity can be improved by using screening libraries that offer maximum diversity while retaining drug-like properties. Faced with a bewildering array of commercially available screening libraries, each with their own differing characteristics, it can be difficult for drug discovery scientists to pick the ideal screening library for their specific requirements.
The Maybridge screening collection consists of over 53,000 organic compounds produced by Thermo Fisher Scientific. These are individually designed compounds produced by innovative synthetic techniques, based on over 45 years of experience in heterocyclic chemistry.
The pre-selected, diverse Maybridge HitFinder screening library makes identifying potential drug leads easy, convenient, and cost-effective. The pre-plated collection consists of 14,400 Maybridge screening compounds, selected to represent the diversity of the Maybridge screening collection using a clustering algorithm based on standard Daylight fingerprints and Tanimoto similarity, and is conveniently supplied as dry films in 96-well plates or 384-well microplates.
Maximize quality hits from your screens
Reduced time to optimize any hit
Ready to screen
The pre-plated Maybridge HitCreator collection consists of 14,000 screening compounds, derived from a rigorous analysis of more than 500,000 commercially available screening compounds. These compounds have been selected using a clustering algorithm, based on standard Daylight fingerprints and Tanimoto similarity. The HitCreator collection is conveniently supplied as dry films in 96-well plates or 384-well microplates.
A ready-to-screen collection of over 51,000 screening compounds in dry film format, the Maybridge HitDiscover collection consists of compounds of minimum 90% purity and pre-plated as 1 µmol dry films in 96-well plate format, offering exceptional diversity and outstanding value. Immediate re-supply is available for the majority of compounds.